Close
Get it on Google Play

Biogen (BIIB) Exercises Option on Amunix License Agreement for Factor IX

January 5, 2017 12:31 PM EST Send to a Friend
Amunix Operating Inc. announced today that Biogen (NASDAQ: BIIB) has exercised its option to enter into an exclusive, worldwide license ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login